Table 1 Cost utility analysis by scenario and treatment group
*
|
Treatment group
|
Mean cost* (£)
|
Mean adjusted QALYs*
|
Incremental cost effectiveness ratio to nearest £100 or comment
|
Manipulation and exercise both available (n=1287)
|
|
|
|
Best care in general practice
|
346
|
0.618
|
|
Best care plus exercise
|
486
|
0.635
|
Dominated by combined treatment, which costs less and gains more QALYs
|
Best care plus manipulation and exercise
|
471
|
0.651
|
£3800
|
Best care plus manipulation
|
541
|
0.659
|
£8700 relative to manipulation and exercise
|
Exercise not available (n=623)
|
|
|
|
Best care in general practice
|
346
|
0.622
|
|
Best care plus manipulation
|
541
|
0.663
|
£4800 relative to best care
|
Manipulation not available (n=668)
|
|
|
|
Best care in general practice
|
346
|
0.610
|
|
Best care plus exercise
|
486
|
0.627
|
£8300 relative to best care
|
|
QALY=quality adjusted life year.
* Markov Chain Monte Carlo estimates from bivariate multilevel model.
Estimated by analysis of covariance with adjustment for baseline EQ-5D score and then rounded to three significant figures.